Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo

Liu,Liang; Zuo,Lian‑Fu; Zuo,Jing; Wang,Jing

doi:10.3892/mmr.2015.3517

Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo

Authors:
- Liang Liu
- Lian‑Fu Zuo
- Jing Zuo
- Jing Wang
View Affiliations

Affiliations: Department of FCM Analysis, Tumor Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
Published online on: March 20, 2015 https://doi.org/10.3892/mmr.2015.3517
Pages: 1465-1472

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Esophageal cancer is a common malignant tumor worldwide with a high incidence rate in China and it is a great threat to human health. Combined modality therapy is used for chemotherapeutic treatment of esophageal cancer; however, drug resistance and side effects of the drugs is a major barrier to the success of chemotherapy. As chemotherapy with common drugs is far from providing satisfactory clinical outcomes for patients with esophageal cancer, more efficient drugs are urgently required. Artesunate (Art) is the first‑line treatment option for malaria; however, it was recently revealed that Art has remarkable anti‑tumor activity, making it a novel candidate for cancer chemotherapy. Although the anti‑cancer effects of Art have been well documented, its potential against esophageal cancer has rarely been explored. The present study aimed to investigate the significance and mechanism of the anti‑proliferative activity of Art on esophageal cancer cells in vitro and in vivo. In the in vitro experiments, Art inhibited the growth as well as induced cell apoptosis and cell cycle arrest of esophageal cancer cell lines (Eca109 and Ec9706) in a concentration‑dependent manner. Furthermore, downregulation of mitochondrial membrane potential, B‑cell lymphoma‑2 (BCL‑2) and CDC25A, as well as upregulation of BCL‑2‑associated X protein (Bax) and caspase‑3 expression in Art‑treated cells were identified. In addition, an in vivo study showed that Art produced a dose‑dependent tumor regression in nude mice, while side effects were low. The anti‑tumor activity of 200 mg/kg Art was similar to that of 3 mg/kg cisplatin. In conclusion, Art exerted concentration‑dependent inhibitory activity against esophageal cancer in vivo and in vitro by inducing cell apoptosis and cell cycle arrest through affecting mitochondrial membrane potential, BCL‑2, Bax, caspase‑3 and CDC25A.

View Figures

View References

1	He SP, Tan GY, Li G, et al: Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay for the antimalaria active ingredient artemisinin in the Chinese herb Artemisia annua L. Anal Bioanal Chem. 393:1297–1303. 2009. View Article : Google Scholar
2	Tanaka H, Putalun W, De-Eknamkul W, Matangkasombut O and Shoyama Y: Preparation of a novel monoclonal antibody against the antimalarial drugs, artemisinin and Art. Planta Med. 73:1127–1132. 2007. View Article : Google Scholar : PubMed/NCBI
3	Harris P, Price S, Senthuran S, Cochupanachimootil J and Norton R: Automated erythrocytapheresis for severe falciparum malaria. Intern Med J. 41:60–63. 2011. View Article : Google Scholar : PubMed/NCBI
4	McLean WG and Ward SA: In vitro neurotoxicity of artemisinin derivatives. Med Trop (Mars). 58(Suppl 3): 28–31. 1998.
5	Efferth T, Dunstan H, Sauerbrey A, Miyachi H and Chitambar CR: The anti-malarial Art is also active against cancer. Int J Oncol. 18:767–773. 2001.PubMed/NCBI
6	Hamacher-Brady A, Stein HA, Turschner S, et al: Art activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem. 286:6587–6601. 2011. View Article : Google Scholar :
7	Blomberg I and Hoffmann I: Ectopic expression of Cdc25A accelerates the G (1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol. 19:6183–6194. 1999.PubMed/NCBI
8	Chen MS, Ryan CE and Piwnica-Worms H: Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol. 23:7488–7497. 2003. View Article : Google Scholar : PubMed/NCBI
9	Galaktionov K, Lee AK, Eckstein J, et al: CDC25 phosphatases as potential human oncogenes. Science. 269:1575–1577. 1995. View Article : Google Scholar : PubMed/NCBI
10	Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J and Lukas J: Regulation of G (2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21:5911–5920. 2002. View Article : Google Scholar : PubMed/NCBI
11	Falck J, Mailand N, Syljuasen RG, Bartek J and Lukas J: The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 410:842–847. 2001. View Article : Google Scholar : PubMed/NCBI
12	Mailand N, Falck J, Lukas C, et al: Rapid destruction of human Cdc25A in response to DNA damage. Science. 288:1425–1429. 2000. View Article : Google Scholar : PubMed/NCBI
13	Molinari M, Mercurio C, Dominguez J, Goubin F and Draetta GF: Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 1:71–79. 2000. View Article : Google Scholar
14	Gasparotto D, Maestro R, Piccinin S, et al: Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res. 57:2366–2368. 1997.PubMed/NCBI
15	Dixon D, Moyana T and King MJ: Elevated expression of the cdc25A protein phosphatase in colon cancer. Exp Cell Res. 240:236–243. 1998. View Article : Google Scholar : PubMed/NCBI
16	Nishioka K, Doki Y, Shiozaki H, et al: Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus. Br J Cancer. 85:412–421. 2001. View Article : Google Scholar : PubMed/NCBI
17	Wu W, Fan YH, Kemp BL, Walsh G and Mao L: Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res. 58:4082–4085. 1998.PubMed/NCBI
18	Siddiqui WA, Ahad A and Ahsan H: The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update. Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
19	Shi LS, Wang H, Wang F, et al: Effects of gastrokine-2 expression on gastric cancer cell apoptosis by activation of extrinsic apoptotic pathways. Mol Med Rep. 10:2898–2904. 2014.PubMed/NCBI
20	Gamliel Z: Incidence, epidemiology and etiology of esophageal cancer. Chest Surg Clin N Am. 10:441–450. 2000.PubMed/NCBI
21	Danis M and Jauréguiberry S: The artemisinin derivatives must be in France the first-line treatment of all P. falciparum malaria cases simple or severe. La Prat. 63:896–898. 2013.In French.
22	Kumnuan R, Pattaradilokrat S, Chumpolbanchorn K, et al: In vivo transmission blocking activities of Art on the avian malaria parasite Plasmodium gallinaceum. Vet Parasitol. 197:447–454. 2013. View Article : Google Scholar : PubMed/NCBI
23	Shanks GD: For severe malaria, Art is the answer. Lancet. 376:1621–1622. 2010. View Article : Google Scholar : PubMed/NCBI
24	Okebe J and Eisenhut M: Pre-referral rectal Art for severe malaria. Cochrane Database Syst Rev. 5:CD0099642014.
25	Steinbruck L, Pereira G and Efferth T: Effects of Art on cytokinesis and G (2)/M cell cycle progression of tumour cells and budding yeast. Cancer Genomics Proteomics. 7:337–346. 2010.
26	Yang H, Tian ST, Wu RY, et al: Glycoborinine induces apoptosis through mitochondrial pathway in HepG2 cells. J Asian Nat Prod Res. 16:991–999. 2014. View Article : Google Scholar : PubMed/NCBI
27	Wimardhani YS, Suniarti DF, Freisleben HJ, Wanandi SI, Siregar NC and Ikeda MA: Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells. J Oral Sci. 56:119–126. 2014. View Article : Google Scholar : PubMed/NCBI
28	Zhou X, Sun WJ, Wang WM, et al: Art inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo. Anticancer Drugs. 24:920–927. 2013. View Article : Google Scholar : PubMed/NCBI
29	Oh KJ, Barbuto S, Pitter K, Morash J, Walensky LD and Korsmeyer SJ: A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro. J Biol Chem. 281:36999–37008. 2006. View Article : Google Scholar : PubMed/NCBI
30	Viry E, Anwar A, Kirsch G, Jacob C, Diederich M and Bagrel D: Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases. Int J Oncol. 38:1103–1111. 2011.PubMed/NCBI
31	Young LM and Pagano M: Cdc25 phosphatases: differential regulation by ubiquitin-mediated proteolysis. Cell Cycle. 9:4613–4614. 2010. View Article : Google Scholar
32	Sengupta S, Jana S and Bhattacharyya A: TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Cell Signal. 26:240–252. 2014. View Article : Google Scholar